Rickard Kathleen A.'s Form 4 filing
Verona Pharma plc (VRNA) · filed Aug 5, 2025
- Accession no.
- 0001104659-25-074397
- Filed
- Aug 5, 2025
- Trade date
- Aug 1, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $766.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rickard Kathleen A.CIK 0001836883 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | Ordinary Shares | MOption exerciseAcquired | +70,888 | $0.00 | $0 | 2,665,808 | Direct | |
| Aug 1, 2025 | Ordinary Shares | SSaleDisposed | −58,336 | $13.14 | −$766,535.04 | 2,607,472 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | Ordinary Shares | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 200,000 | Direct | |
| Aug 1, 2025 | Ordinary Shares | MOption exerciseDisposed | −20,888 | $0.00 | $0 | 146,168 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.